BL
Therapeutic Areas
Xcovery Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Ensartinib (Ensacove™) | ALK-positive Non-Small Cell Lung Cancer (NSCLC) | Approved |
| Vorolanib | Various cancers (as monotherapy and combination with IO) | Phase 2/3 |
| Drug | Indication | Phase |
|---|---|---|
| Ensartinib (Ensacove™) | ALK-positive Non-Small Cell Lung Cancer (NSCLC) | Approved |
| Vorolanib | Various cancers (as monotherapy and combination with IO) | Phase 2/3 |